Well Cell Global, LLC Proprietary Technology & Patent Defense
The High-Stakes Challenge
Adverse commercial competitors and former clinical licensees challenged core proprietary patent claims and sought to exploit trade secret assets across highly competitive medical technology and clinical delivery markets.
Procedural Background & Motions
Concurrent federal district court litigation and patent review filings threatened the client's global licensing relationships, intellectual property exclusivity, and commercial expansion.
Our Legal Strategy
Constructed comprehensive patent claim construction frameworks, conducted deep forensic trade secret exposure audits, and enforced strict restrictive covenant agreements to neutralize adverse misappropriation efforts under both DTSA and TUTSA.
The Outcome & Results
Successfully defended proprietary biomedical innovation assets and enforced core technology protections, securing an outcome valued at over $17 Million for the client.
“Protecting biomedical and proprietary tech assets requires an integrated defense strategy that harmonizes patent claim construction with aggressive trade secret enforcement.”
Discuss a Similar High-Stakes Matter
Confidential case audit conducted directly by lead trial counsel.